George K. Tofaris

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Compartment-specific correlation of pathological α-synuclein in prodromal Parkinson's disease.

Compartment-specific correlation of pathological α-synuclein in prodromal Parkinson's disease.

Journal: Parkinsonism & related disorders

Published: November 10, 2025

α-Synuclein blocks endoplasmic reticulum co-translational protein translocation early in Parkinson's disease.

α-Synuclein blocks endoplasmic reticulum co-translational protein translocation early in Parkinson's disease.

Journal: Nature communications

Published: October 05, 2025

Serum p-tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder.

Serum p-tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder.

Journal: Annals of neurology

Published: August 05, 2025

Palindrome-mediated 16p13.3 triplications cause a recognizable neurodegenerative disorder with ataxia.

Palindrome-mediated 16p13.3 triplications cause a recognizable neurodegenerative disorder with ataxia.

Journal: American journal of human genetics

Published: July 28, 2025

In vivo validation of novel non-invasive PHP.eB AAVs as a potential therapeutic approach for alpha-synucleinopathies.

In vivo validation of novel non-invasive PHP.eB AAVs as a potential therapeutic approach for alpha-synucleinopathies.

Journal: Acta neuropathologica communications

Published: May 27, 2025

Decade-Long Prodrome on Neuroimaging: Unique Insight into Probable Corticobasal Degeneration.

Decade-Long Prodrome on Neuroimaging: Unique Insight into Probable Corticobasal Degeneration.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: April 23, 2025

Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.

Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: December 06, 2024

Working memory filtering at encoding and maintenance in healthy ageing, Alzheimer's and Parkinson's disease.

Working memory filtering at encoding and maintenance in healthy ageing, Alzheimer's and Parkinson's disease.

Journal: Scientific reports

Published: November 08, 2024

Single extracellular vesicle detection assay identifies membrane-associated α-synuclein as an early-stage biomarker in Parkinson's disease.

Single extracellular vesicle detection assay identifies membrane-associated α-synuclein as an early-stage biomarker in Parkinson's disease.

Journal: Cell reports. Medicine

Published: October 10, 2024

Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease.

Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease.

Journal: JAMA neurology

Published: December 04, 2023

Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy.

Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: August 31, 2023

Detailed Analysis of ITPR1 Missense Variants Guides Diagnostics and Therapeutic Design.

Detailed Analysis of ITPR1 Missense Variants Guides Diagnostics and Therapeutic Design.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: July 30, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026